MRNA · 8-K · 20261106PR000194

Outstanding Indebtedness

Moderna, Inc. · 2026-11-06 · Importance 72 · Surprise 42 · In source text

In September 2026, Moderna completed a convertible senior notes offering with approximately $3.0 billion principal amount and received approximately $2.6 billion in net proceeds after capped-call purchases and fees. The capped calls were designed to mitigate potential future dilution, and the financing was intended to provide flexibility for oncology investment and future debt obligations. At September 30, the balance sheet reported $2.958 billion of convertible notes and $591 million of long-term debt. Cash-flow reporting showed $3.0 billion of note proceeds, $43 million of issuance costs and $329 million paid for capped calls.

Key facts

• Moderna completed a convertible senior notes offering in September 2026 totaling approximately $3.0 billion in principal amount. source

Impact estimates